MétaCan
Menu
Back to cohort
Record W2975743545 · doi:10.1016/j.dadm.2019.08.002

Plasma neurofilament light associates with Alzheimer's disease metabolic decline in amyloid‐positive individuals

2019· article· en· W2975743545 on OpenAlexafffund
Andréa Lessa Benedet, Nicholas J. Ashton, Tharick A. Pascoal, Antoine Leuzy, Sulantha Mathotaarachchi, Min Su Kang, Joseph Therriault, Mélissa Savard, Mira Chamoun, Michael Schöll, Eduardo R. Zimmer, Serge Gauthier, Aurélie Labbe, Henrik Zetterberg, Kaj Blennow, Pedro Rosa‐Neto

Bibliographic record

VenueAlzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2019
Typearticle
Languageen
FieldMedicine
TopicAlzheimer's disease research and treatments
Canadian institutionsMontreal Neurological Institute and HospitalHEC MontréalMcGill University Health CentreMcGill University
FundersNational Institute on AgingNational Institute of Biomedical Imaging and BioengineeringCanadian Institutes of Health ResearchGenentechNational Institutes of HealthUK Dementia Research InstituteH. Lundbeck A/SServierInstituto Nacional de Ciência e Tecnologia para Excitotoxicidade e NeuroproteçãoGöteborgs UniversitetFundação de Amparo à Pesquisa do Estado do Rio Grande do SulVetenskapsrådetEisaiConselho Nacional de Desenvolvimento Científico e TecnológicoCoordenação de Aperfeiçoamento de Pessoal de Nível SuperiorAlzheimer's Drug Discovery FoundationWeston Brain InstituteNorthern California Institute for Research and EducationPfizerBiogenBioClinicaTorsten Söderbergs StiftelseF. Hoffmann-La RocheRocheUniversity of Southern CaliforniaNovartis Pharmaceuticals CorporationU.S. Department of DefenseEli Lilly and CompanyConsortium canadien en neurodégénérescence associée au vieillissementBristol-Myers SquibbIXICOTakeda Pharmaceutical CompanyAbbVieAlzheimer's AssociationFoundation for the National Institutes of HealthGE HealthcareAlzheimer's Disease Neuroimaging InitiativeMeso Scale Diagnostics
KeywordsNeurodegenerationCerebrospinal fluidBiomarkerAlzheimer's diseaseDiseasePathologyInternal medicinePsychologyMedicineAmyloid (mycology)OncologyNeuroscienceBiologyBiochemistry

Abstract

fetched live from OpenAlex

Abstract Introduction Neurofilament light chain (NfL) is a promising blood biomarker to detect neurodegeneration in Alzheimer's disease (AD) and other brain disorders. However, there are limited reports of how longitudinal NfL relates to imaging biomarkers. We herein investigated the relationship between blood NfL and brain metabolism in AD. Methods Voxelwise regression models tested the cross‐sectional association between [ 18 F]fluorodeoxyglucose ([ 18 F]FDG) and both plasma and cerebrospinal fluid NfL in cognitively impaired and unimpaired subjects. Linear mixed models were also used to test the longitudinal association between NfL and [ 18 F]FDG in amyloid positive (Aβ+) and negative (Aβ−) subjects. Results Higher concentrations of plasma and cerebrospinal fluid NfL were associated with reduced [ 18 F]FDG uptake in correspondent brain regions. In Aβ+ participants, NfL associates with hypometabolism in AD‐vulnerable regions. Longitudinal changes in the association [ 18 F]FDG‐NfL were confined to cognitively impaired Aβ+ individuals. Discussion These findings indicate that plasma NfL is a proxy for neurodegeneration in AD‐related regions in Aβ+ subjects.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.133
Threshold uncertainty score0.999

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.001
Open science0.0010.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.023
GPT teacher head0.322
Teacher spread0.299 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations80
Published2019
Admission routes2
Has abstractyes

Explore more

Same venueAlzheimer s & Dementia Diagnosis Assessment & Disease MonitoringSame topicAlzheimer's disease research and treatmentsFrench-language works237,207